Safety and Efficacy of Vilazodone in Major Depressive Disorder
Public ClinicalTrials.gov record NCT01573598. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Study identification
- NCT ID
- NCT01573598
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,219 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2012
- Primary completion
- Sep 30, 2014
- Completion
- Dec 31, 2014
- Last update posted
- May 17, 2015
2012 – 2015
United States locations
- U.S. sites
- 38
- U.S. states
- 14
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 030 | Beverly Hills | California | 90210 | — |
| Forest Investigative Site 012 | Chino | California | 91710 | — |
| Forest Investigative Site 022 | Costa Mesa | California | 92626 | — |
| Forest Investigative Site 017 | Los Angeles | California | 90024 | — |
| Forest Investigative Site 005 | Newport Beach | California | 92660 | — |
| Forest Investigative Site 027 | Riverside | California | 92506 | — |
| Forest Investigative Site 026 | San Diego | California | 92103 | — |
| Forest Investigative Site 016 | Cromwell | Connecticut | 06416 | — |
| Forest Investigative Site 029 | Hartford | Connecticut | 06106 | — |
| Forest Investigative Site 020 | Doral | Florida | 33172 | — |
| Forest Investigative Site 007 | Fort Lauderdale | Florida | 33313 | — |
| Forest Investigative Site 006 | Fort Myers | Florida | 33912 | — |
| Forest Investigative Site 004 | Hallandale | Florida | 33009 | — |
| Forest Investigative Site 039 | Jacksonville | Florida | 32256 | — |
| Forest Investigative Site 008 | Jacksonville Beach | Florida | 32250 | — |
| Forest Investigative Site 015 | Leesburg | Florida | 34748 | — |
| Forest Investigative Site 035 | Orlando | Florida | 32806 | — |
| Forest Investigative Site 001 | West Palm Beach | Florida | 33407 | — |
| Forest Investigative Site 034 | Winter Park | Florida | 32789 | — |
| Forest Investigative Site 019 | Hoffman Estates | Illinois | 60169 | — |
| Forest Investigative Site 021 | Indianapolis | Indiana | 46260 | — |
| Forest Investigative Site 003 | Boston | Massachusetts | 02131 | — |
| Forest Investigative Site 013 | Weymouth | Massachusetts | 02190 | — |
| Forest Investigative Site 028 | Rochester Hills | Michigan | 48307 | — |
| Forest Investigative Site 038 | Brooklyn | New York | 11214 | — |
| Forest Investigative Site 037 | New York | New York | 10003 | — |
| Forest Investigative Site 032 | New York | New York | 10021 | — |
| Forest Investigative Site 009 | New York | New York | 10032 | — |
| Forest Investigative Site 014 | Durham | North Carolina | 27705 | — |
| Forest Investigative Site 025 | Oklahoma City | Oklahoma | 73103 | — |
| Forest Investigative Site 024 | Oklahoma City | Oklahoma | 73112 | — |
| Forest Investigative Site 036 | Memphis | Tennessee | 38119 | — |
| Forest Investigative Site 023 | Dallas | Texas | 75080 | — |
| Forest Investigative Site 011 | Houston | Texas | 77079 | — |
| Forest Investigative Site 010 | Plano | Texas | 75093 | — |
| Forest Investigative Site 002 | San Antonio | Texas | 78229 | — |
| Forest Investigative Site 031 | Richmond | Virginia | 23298 | — |
| Forest Investigative Site 033 | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
Recently updated Major Depressive Disorder trials
Other public records listing Major Depressive Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT07772531: A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder Not yet recruiting
- NCT05850689: Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder Recruiting
- NCT03437928: DBS for Depression Recruiting
- NCT07196501: A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) Recruiting
- NCT07115329: A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder Recruiting
- NCT06376734: Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01573598, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 17, 2015 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01573598 live on ClinicalTrials.gov.